Abstract:By the end of the 1950s Hungary became an unlikely leader in what we now call global health. Only three years after Soviet tanks crushed the revolution of 1956, Hungary became one of the first countries to introduce the Sabin vaccine into its national vaccination programme. This immunisation campaign was built on years of scientific collaboration between East and West, in which scientists, specimens, vaccines and iron lungs crossed over the Iron Curtain. Dóra Vargha uses a series of polio epidemics in communis… Show more
“…Due to these attributes, it gained attention from scientists to bureaucrats, as the characteristics of the disease merged with the characteristics of the post-war era. While treating the polio challenged demographic was the goal, the process also improved the manufacturing technology, the theory and practice of medicine, and renewed the obsession with child propaganda and humanitarian work (Vargha 2018).…”
Section: Backroundmentioning
confidence: 99%
“…Furthermore, some articles highlighted the economic repercussions of the epidemic; the feasibility of the quarantine and the costs incurred in terms of their impact on trade. In addition to these, the subjugation of political independence in the fight against the epidemic was an important topic as well (Vargha 2018).…”
Section: Backroundmentioning
confidence: 99%
“…"; etc. Dora Vargha's recent book also points out (Vargha 2018) that although living with the disease is an individual experience, it requires health protection and disease management from a global perspective. Which also means that not only the individual but also international politics and relations have a role to play in it.…”
Aim
The number of Hungarian polio patients can be estimated at approximately 3000. Polio infection is currently affecting people 56–65 years of age. The aim of the study was to reveal the quality of life of patients living with polio virus in Hungary.
Subject and methods
The quantitative cross-sectional study was conducted in January–April 2017 among polyomyelitis patients living in Hungary. In the non-random, targeted, expert sample selection, the target group was composed of patients infected with poliovirus (N = 268). We have excluded those who refused to sign the consent statement. Our data collection method was an SF-36 questionnaire. Using the IBM SPSS Statistics Version 22 program, descriptive and mathematical statistics (χ2-test) were calculated (p < 0.05).
Results
The mean age of the members of the examined population is 63.5 years; 68.1% were women and 31.90% were men. The majority of the respondents were infected by the polyovirus in 1956 (11.9%), 1957 (24.3%), and 1959 (19.5%). Polio patients, with the exception of two dimensions (mental health, social operation), on the scale of 100 do not reach the “average” quality of life (physical functioning 23 points, functional role 36 points, emotional role 47 points, body pain 48 points, general health 42 points, vitality 50 points, health change 31 points).
Conclusion
The quality of life of polio patients is far below the dimensions of physical function, while the difference in mental health compared to healthy people is minimal. It would be important to educate health professionals about the existing disease, to develop an effective rehabilitation method.
“…Due to these attributes, it gained attention from scientists to bureaucrats, as the characteristics of the disease merged with the characteristics of the post-war era. While treating the polio challenged demographic was the goal, the process also improved the manufacturing technology, the theory and practice of medicine, and renewed the obsession with child propaganda and humanitarian work (Vargha 2018).…”
Section: Backroundmentioning
confidence: 99%
“…Furthermore, some articles highlighted the economic repercussions of the epidemic; the feasibility of the quarantine and the costs incurred in terms of their impact on trade. In addition to these, the subjugation of political independence in the fight against the epidemic was an important topic as well (Vargha 2018).…”
Section: Backroundmentioning
confidence: 99%
“…"; etc. Dora Vargha's recent book also points out (Vargha 2018) that although living with the disease is an individual experience, it requires health protection and disease management from a global perspective. Which also means that not only the individual but also international politics and relations have a role to play in it.…”
Aim
The number of Hungarian polio patients can be estimated at approximately 3000. Polio infection is currently affecting people 56–65 years of age. The aim of the study was to reveal the quality of life of patients living with polio virus in Hungary.
Subject and methods
The quantitative cross-sectional study was conducted in January–April 2017 among polyomyelitis patients living in Hungary. In the non-random, targeted, expert sample selection, the target group was composed of patients infected with poliovirus (N = 268). We have excluded those who refused to sign the consent statement. Our data collection method was an SF-36 questionnaire. Using the IBM SPSS Statistics Version 22 program, descriptive and mathematical statistics (χ2-test) were calculated (p < 0.05).
Results
The mean age of the members of the examined population is 63.5 years; 68.1% were women and 31.90% were men. The majority of the respondents were infected by the polyovirus in 1956 (11.9%), 1957 (24.3%), and 1959 (19.5%). Polio patients, with the exception of two dimensions (mental health, social operation), on the scale of 100 do not reach the “average” quality of life (physical functioning 23 points, functional role 36 points, emotional role 47 points, body pain 48 points, general health 42 points, vitality 50 points, health change 31 points).
Conclusion
The quality of life of polio patients is far below the dimensions of physical function, while the difference in mental health compared to healthy people is minimal. It would be important to educate health professionals about the existing disease, to develop an effective rehabilitation method.
Transnational history is a research perspective that has been widely legitimized and popularized over the past decade, but few disability historians have adopted this approach to date. This article aims to review the first transnational studies in the history of disability, highlighting the interest of such a historiographical approach, its benefits and disadvantages. The approach to transnational history continues to be promoted mainly by young historians working in non-Western fields (Eastern Europe, Latin America, Africa) or with a global approach. This innovative historiographical approach generates considerable contributions in terms of knowledge and research perspective. It offers a new reading of history, less nationalcentric and Western-centric, by shifting the focus to other countries in the world whose experiences in disability public policy must not be ignored by Western historians. It highlights the role of NGOs, private foundations, transnational activist networks, intergovernmental organizations, and new figures (international experts, missionaries, etc.). It thus requires recognition of the foreign contribution to the construction of domestic norms and realities, and thus the hybridity of policies pursued at the national level. It also leads to relativizing the singularity of national social movements and national public policies, by pointing out convergences (and divergences) with other national realities. The adoption of such an approach also leads to situating local or national experience in a more global historical context (international or regional scale), thanks to a better knowledge of the "field of possibilities" of disability policies at the international level.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.